1.
Neuromodulation
; 23(1): 3-9, 2020 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31965667
RESUMO
The United States Food and Drug Administration (FDA) ensures that patients in the United States have access to safe and effective medical devices. The division of neurological and physical medicine devices reviews medical technologies that interface with the nervous system, including many neuromodulation devices. This article focuses on neuromodulation devices and addresses how to navigate the FDA's regulatory landscape to successfully bring devices to patients.